ArticleJournal of autism and developmental disorders2026
Brief Report: Healthcare Utilization and Expenditure Trends Among Autistic Transition Age Youth.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThe transition to adult healthcare is a vulnerable time for individuals with autism spectrum disorder (ASD). Prior research using Medicaid data (2001–2005) found this group had declining utilization rates into adulthood for some types of care (e.g., psychiatric outpatient). Substantial changes to Medicaid and the ASD population have occurred since this time. We reassessed healthcare resource utilization (HCRU) across the transition to adulthood Medicaid claims data from 2015 to 2019.
methodsWe selected enrollees with at least one fee for service claim, aged 16–19 years in 2015, who were also enrolled in 2019 using diagnostic groupings: ASD/no ID (n = 23,460), ID/no ASD (n = 21,256) and ASD + ID (n = 10,115). HCRU indicators included utilization rates and per capita expenditures for outpatient, inpatient, long-term, and medication care, with each type further divided into psychiatric and non-psychiatric (i.e., medical).
resultsThe ID groups had overall higher HCRU than the ASD only group. ASD + ID adults had especially high HCRU for psychiatric outpatient care. HCRU increased into adulthood for psychiatric outpatient and long-term care, driven by higher expenditures among those with >$0 expenditures. HCRU declined into adulthood for inpatient care and medication use.
conclusionIn contrast to 2001–2005, having an ID diagnosis resulted in greater HRCU across transition to adulthood, potentially reflecting changes in the Medicaid ASD population over time. Consistent with 2001–2005, utilization rates generally declined for all three groups across the transition to adulthood. Greater expenditure among those using psychiatric outpatient and long-term care in adulthood resulted in greater overall resource utilization than adolescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.